Europe Generic drug Market Report 2016

November 2016 | 113 pages | ID: EFFA269A834EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Generic drug

Revenue, means the sales value of Generic drug

This report studies sales (consumption) of Generic drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Teva Pharmaceuticals
• Sandoz
• Allergan
• Mylan
• Sun Pharmaceuticals
• STADA Arzneimittel
• Abbott
• Baxter
• Boehringer Ingelheim
• Daiichi Sankyo
• Eli Lilly
• GlaxoSmithKline
• Mitsubishi Tanabe Pharma
• Pfizer
• Roche
• Sanofi

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Generic drug in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Generic drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Generic drug Market Report 2016

1 GENERIC DRUG OVERVIEW

1.1 Product Overview and Scope of Generic drug
1.2 Classification of Generic drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Generic drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Generic drug Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Generic drug (2011-2021)
  1.5.1 Europe Generic drug Sales and Growth Rate (2011-2021)
  1.5.2 Europe Generic drug Revenue and Growth Rate (2011-2021)

2 EUROPE GENERIC DRUG BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Generic drug Market Competition by Manufacturers
  2.1.1 Europe Generic drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Generic drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Generic drug (Volume and Value) by Type
  2.2.1 Europe Generic drug Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Generic drug Revenue and Market Share by Type (2011-2016)
2.3 Europe Generic drug (Volume and Value) by Countries
  2.3.1 Europe Generic drug Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Generic drug Revenue and Market Share by Countries (2011-2016)
2.4 Europe Generic drug (Volume) by Application

3 GERMANY GENERIC DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Generic drug Sales and Value (2011-2016)
  3.1.1 Germany Generic drug Sales and Growth Rate (2011-2016)
  3.1.2 Germany Generic drug Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Generic drug Sales Price Trend (2011-2016)
3.2 Germany Generic drug Sales and Market Share by Manufacturers
3.3 Germany Generic drug Sales and Market Share by Type
3.4 Germany Generic drug Sales and Market Share by Application

4 FRANCE GENERIC DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 France Generic drug Sales and Value (2011-2016)
  4.1.1 France Generic drug Sales and Growth Rate (2011-2016)
  4.1.2 France Generic drug Revenue and Growth Rate (2011-2016)
  4.1.4 France Generic drug Sales Price Trend (2011-2016)
4.2 France Generic drug Sales and Market Share by Manufacturers
4.3 France Generic drug Sales and Market Share by Type
4.4 France Generic drug Sales and Market Share by Application

5 UK GENERIC DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 UK Generic drug Sales and Value (2011-2016)
  5.1.1 UK Generic drug Sales and Growth Rate (2011-2016)
  5.1.2 UK Generic drug Revenue and Growth Rate (2011-2016)
  5.1.5 UK Generic drug Sales Price Trend (2011-2016)
5.2 UK Generic drug Sales and Market Share by Manufacturers
5.3 UK Generic drug Sales and Market Share by Type
5.4 UK Generic drug Sales and Market Share by Application

6 RUSSIA GENERIC DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Generic drug Sales and Value (2011-2016)
  6.1.1 Russia Generic drug Sales and Growth Rate (2011-2016)
  6.1.2 Russia Generic drug Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Generic drug Sales Price Trend (2011-2016)
6.2 Russia Generic drug Sales and Market Share by Manufacturers
6.3 Russia Generic drug Sales and Market Share by Type
6.4 Russia Generic drug Sales and Market Share by Application

7 ITALY GENERIC DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Generic drug Sales and Value (2011-2016)
  7.1.1 Italy Generic drug Sales and Growth Rate (2011-2016)
  7.1.2 Italy Generic drug Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Generic drug Sales Price Trend (2011-2016)
7.2 Italy Generic drug Sales and Market Share by Manufacturers
7.3 Italy Generic drug Sales and Market Share by Type
7.4 Italy Generic drug Sales and Market Share by Application

8 SPAIN GENERIC DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Generic drug Sales and Value (2011-2016)
  8.1.1 Spain Generic drug Sales and Growth Rate (2011-2016)
  8.1.2 Spain Generic drug Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Generic drug Sales Price Trend (2011-2016)
8.2 Spain Generic drug Sales and Market Share by Manufacturers
8.3 Spain Generic drug Sales and Market Share by Type
8.4 Spain Generic drug Sales and Market Share by Application

9 BENELUX GENERIC DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Generic drug Sales and Value (2011-2016)
  9.1.1 Benelux Generic drug Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Generic drug Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Generic drug Sales Price Trend (2011-2016)
9.2 Benelux Generic drug Sales and Market Share by Manufacturers
9.3 Benelux Generic drug Sales and Market Share by Type
9.4 Benelux Generic drug Sales and Market Share by Application

10 EUROPE GENERIC DRUG MANUFACTURERS ANALYSIS

10.1 Teva Pharmaceuticals
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Generic drug Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Teva Pharmaceuticals Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Sandoz
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Generic drug Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Sandoz Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Allergan
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Generic drug Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Allergan Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Mylan
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Generic drug Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Mylan Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Sun Pharmaceuticals
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Generic drug Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Sun Pharmaceuticals Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 STADA Arzneimittel
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Generic drug Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 STADA Arzneimittel Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Abbott
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Generic drug Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Abbott Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Baxter
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Generic drug Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Baxter Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Boehringer Ingelheim
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Generic drug Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Boehringer Ingelheim Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Daiichi Sankyo
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Generic drug Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Daiichi Sankyo Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Eli Lilly
10.12 GlaxoSmithKline
10.13 Mitsubishi Tanabe Pharma
10.14 Pfizer
10.15 Roche
10.16 Sanofi

11 GENERIC DRUG MANUFACTURING COST ANALYSIS

11.1 Generic drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Generic drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Generic drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Generic drug Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE GENERIC DRUG MARKET FORECAST (2016-2021)

14.1 Germany Generic drug Sales Forecast (2016-2021)
14.2 France Generic drug Sales Forecast (2016-2021)
14.3 UK Generic drug Sales Forecast (2016-2021)
14.4 Russia Generic drug Sales Forecast (2016-2021)
14.5 Italy Generic drug Sales Forecast (2016-2021)
14.6 Spain Generic drug Sales Forecast (2016-2021)
14.7 Benelux Generic drug Sales Forecast (2016-2021)
14.8 Europe Generic drug Sales Forecast by Type (2016-2021)
14.9 Europe Generic drug Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Generic drug
Table Classification of Generic drug
Figure Europe Sales Market Share of Generic drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Generic drug
Figure Europe Sales Market Share of Generic drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Generic drug Revenue and Growth Rate (2011-2021)
Figure France Generic drug Revenue and Growth Rate (2011-2021)
Figure UK Generic drug Revenue and Growth Rate (2011-2021)
Figure Russia Generic drug Revenue and Growth Rate (2011-2021)
Figure Italy Generic drug Revenue and Growth Rate (2011-2021)
Figure Spain Generic drug Revenue and Growth Rate (2011-2021)
Figure Benelux Generic drug Revenue and Growth Rate (2011-2021)
Figure Europe Generic drug Sales and Growth Rate (2011-2021)
Figure Europe Generic drug Revenue and Growth Rate (2011-2021)
Table Europe Generic drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Generic drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Generic drug Sales Share by Manufacturers
Figure 2016 Generic drug Sales Share by Manufacturers
Table Europe Generic drug Revenue by Manufacturers (2015 and 2016)
Table Europe Generic drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Generic drug Revenue Share by Manufacturers
Table 2016 Europe Generic drug Revenue Share by Manufacturers
Table Europe Generic drug Sales and Market Share by Type (2011-2016)
Table Europe Generic drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Generic drug by Type (2011-2016)
Figure Europe Generic drug Sales Growth Rate by Type (2011-2016)
Table Europe Generic drug Revenue and Market Share by Type (2011-2016)
Table Europe Generic drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Generic drug by Type (2011-2016)
Figure Europe Generic drug Revenue Growth Rate by Type (2011-2016)
Table Europe Generic drug Sales and Market Share by Countries (2011-2016)
Table Europe Generic drug Sales Share by Countries (2011-2016)
Figure Sales Market Share of Generic drug by Countries (2011-2016)
Table Europe Generic drug Revenue and Market Share by Countries (2011-2016)
Table Europe Generic drug Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Generic drug by Countries (2011-2016)
Table Europe Generic drug Sales and Market Share by Application (2011-2016)
Table Europe Generic drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Generic drug by Application (2011-2016)
Figure Germany Generic drug Sales and Growth Rate (2011-2016)
Figure Germany Generic drug Revenue and Growth Rate (2011-2016)
Figure Germany Generic drug Sales Price Trend (2011-2016)
Table Germany Generic drug Sales by Manufacturers (2015 and 2016)
Table Germany Generic drug Market Share by Manufacturers (2015 and 2016)
Table Germany Generic drug Sales by Type (2015 and 2016)
Table Germany Generic drug Market Share by Type (2015 and 2016)
Table Germany Generic drug Sales by Application (2015 and 2016)
Table Germany Generic drug Market Share by Application (2015 and 2016)
Figure France Generic drug Sales and Growth Rate (2011-2016)
Figure France Generic drug Revenue and Growth Rate (2011-2016)
Figure France Generic drug Sales Price Trend (2011-2016)
Table France Generic drug Sales by Manufacturers (2015 and 2016)
Table France Generic drug Market Share by Manufacturers (2015 and 2016)
Table France Generic drug Sales by Type (2015 and 2016)
Table France Generic drug Market Share by Type (2015 and 2016)
Table France Generic drug Sales by Application (2015 and 2016)
Table France Generic drug Market Share by Application (2015 and 2016)
Figure UK Generic drug Sales and Growth Rate (2011-2016)
Figure UK Generic drug Revenue and Growth Rate (2011-2016)
Figure UK Generic drug Sales Price Trend (2011-2016)
Table UK Generic drug Sales by Manufacturers (2015 and 2016)
Table UK Generic drug Market Share by Manufacturers (2015 and 2016)
Table UK Generic drug Sales by Type (2015 and 2016)
Table UK Generic drug Market Share by Type (2015 and 2016)
Table UK Generic drug Sales by Application (2015 and 2016)
Table UK Generic drug Market Share by Application (2015 and 2016)
Figure Russia Generic drug Sales and Growth Rate (2011-2016)
Figure Russia Generic drug Revenue and Growth Rate (2011-2016)
Figure Russia Generic drug Sales Price Trend (2011-2016)
Table Russia Generic drug Sales by Manufacturers (2015 and 2016)
Table Russia Generic drug Market Share by Manufacturers (2015 and 2016)
Table Russia Generic drug Sales by Type (2015 and 2016)
Table Russia Generic drug Market Share by Type (2015 and 2016)
Table Russia Generic drug Sales by Application (2015 and 2016)
Table Russia Generic drug Market Share by Application (2015 and 2016)
Figure Italy Generic drug Sales and Growth Rate (2011-2016)
Figure Italy Generic drug Revenue and Growth Rate (2011-2016)
Figure Italy Generic drug Sales Price Trend (2011-2016)
Table Italy Generic drug Sales by Manufacturers (2015 and 2016)
Table Italy Generic drug Market Share by Manufacturers (2015 and 2016)
Table Italy Generic drug Sales by Type (2015 and 2016)
Table Italy Generic drug Market Share by Type (2015 and 2016)
Table Italy Generic drug Sales by Application (2015 and 2016)
Table Italy Generic drug Market Share by Application (2015 and 2016)
Figure Spain Generic drug Sales and Growth Rate (2011-2016)
Figure Spain Generic drug Revenue and Growth Rate (2011-2016)
Figure Spain Generic drug Sales Price Trend (2011-2016)
Table Spain Generic drug Sales by Manufacturers (2015 and 2016)
Table Spain Generic drug Market Share by Manufacturers (2015 and 2016)
Table Spain Generic drug Sales by Type (2015 and 2016)
Table Spain Generic drug Market Share by Type (2015 and 2016)
Table Spain Generic drug Sales by Application (2015 and 2016)
Table Spain Generic drug Market Share by Application (2015 and 2016)
Figure Benelux Generic drug Sales and Growth Rate (2011-2016)
Figure Benelux Generic drug Revenue and Growth Rate (2011-2016)
Figure Benelux Generic drug Sales Price Trend (2011-2016)
Table Benelux Generic drug Sales by Manufacturers (2015 and 2016)
Table Benelux Generic drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Generic drug Sales by Type (2015 and 2016)
Table Benelux Generic drug Market Share by Type (2015 and 2016)
Table Benelux Generic drug Sales by Application (2015 and 2016)
Table Benelux Generic drug Market Share by Application (2015 and 2016)
Table Generic drug Basic Information List
Table Teva Pharmaceuticals Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceuticals Generic drug Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Generic drug Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Generic drug Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Generic drug Sales Market Share (2011-2016)
Table Sun Pharmaceuticals Basic Information List
Table Sun Pharmaceuticals Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceuticals Generic drug Sales Market Share (2011-2016)
Table STADA Arzneimittel Basic Information List
Table STADA Arzneimittel Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table STADA Arzneimittel Generic drug Sales Market Share (2011-2016)
Table Abbott Basic Information List
Table Abbott Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Generic drug Sales Market Share (2011-2016)
Table Baxter Basic Information List
Table Baxter Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter Generic drug Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Generic drug Sales Market Share (2011-2016)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo Generic drug Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Generic drug Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Generic drug Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Basic Information List
Table Mitsubishi Tanabe Pharma Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Generic drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Generic drug Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Generic drug Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Generic drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Generic drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Generic drug
Figure Manufacturing Process Analysis of Generic drug
Figure Generic drug Industrial Chain Analysis
Table Raw Materials Sources of Generic drug Major Manufacturers in 2015
Table Major Buyers of Generic drug
Table Distributors/Traders List
Figure Germany Generic drug Sales and Growth Rate Forecast (2016-2021)
Figure Germany Generic drug Revenue and Growth Rate Forecast (2016-2021)
Figure France Generic drug Sales and Growth Rate Forecast (2016-2021)
Figure France Generic drug Revenue and Growth Rate Forecast (2016-2021)
Figure UK Generic drug Sales and Growth Rate Forecast (2016-2021)
Figure UK Generic drug Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Generic drug Sales and Growth Rate Forecast (2016-2021)
Figure Russia Generic drug Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Generic drug Sales and Growth Rate Forecast (2016-2021)
Figure Italy Generic drug Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Generic drug Sales and Growth Rate Forecast (2016-2021)
Figure Spain Generic drug Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Generic drug Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Generic drug Revenue and Growth Rate Forecast (2016-2021)
Table Europe Generic drug Sales Forecast by Type (2016-2021)
Table Europe Generic drug Sales Forecast by Application (2016-2021)